Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA)

Q: What does CUSIP 426897104 represent in this 13F holders report?

CUSIP 426897104 is the security identifier for HEPA - Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held HEPA - Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in Q1 2021?

39 institutional investors reported HEPA - Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share for Q1 2021. Use the holders table for investor-level position and value details.

CUSIP: 426897104

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 29,123,952
Total 13F shares: 7,972,408
Share change: +2,424,070
Total reported value: $14,665,458
Put/Call ratio: 133%
Price per share: $1.84
Number of holders: 39
Value change: +$3,900,185
Number of buys: 32
Number of sells: 11

Security key

426897104

Report period

Q1 2021

Institutions

Top holders

HEPA full security history Newer quarter: Q2 2021 Previous quarter: Q4 2020 Hepion Pharmaceuticals, Inc. SEC filings Hepion Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 426897104

Newer quarter: Q2 2021 Previous quarter: Q4 2020

Recent filing periods:

Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021

Top shareholders of HEPA - Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	5.9%	1,728,604	$3,786,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	4.1%	1,194,348	$2,616,000	—	31 Dec 2020	13F
AIGH Capital Management LLC	13F	Company	3.2%	923,230	$2,022,000	—	31 Dec 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.1%	329,022	$721,000	—	31 Dec 2020	13F
Worth Venture Partners, LLC	13F	Company	0.8%	233,947	$512,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.7%	202,555	$443,000	—	31 Dec 2020	13F
PERKINS CAPITAL MANAGEMENT INC	13F	Company	0.52%	150,000	$329,000	—	31 Dec 2020	13F
Squarepoint Ops LLC	13F	Company	0.38%	111,978	$245,000	—	31 Dec 2020	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.33%	95,300	$208,000	—	31 Dec 2020	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.31%	89,067	$195,000	—	31 Dec 2020	13F
PREMIER ASSET MANAGEMENT LLC	13F	Company	0.24%	70,000	$153,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.22%	63,402	$139,000	—	31 Dec 2020	13F
ZEKE CAPITAL ADVISORS, LLC	13F	Company	0.17%	50,000	$110,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.14%	40,943	$90,000	—	31 Dec 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.14%	40,232	$88,000	—	31 Dec 2020	13F
Prospera Financial Services Inc	13F	Company	0.13%	39,300	$86,000	—	31 Dec 2020	13F
Allen Capital Group, LLC	13F	Company	0.08%	23,685	$52,000	—	31 Dec 2020	13F
Onex Canada Asset Management Inc.	13F	Company	0.07%	20,000	$44,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.04%	11,079	$24,000	—	31 Dec 2020	13F
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	0.04%	10,360	$22,000	—	31 Dec 2020	13F
Bank Julius Baer & Co. Ltd, Zurich	13F	Company	0.03%	8,219	$18,000	—	31 Dec 2020	13F
Sowell Financial Services LLC	13F	Company	0.03%	7,318	$16,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0.02%	6,317	$14,000	—	31 Dec 2020	13F
IFP Advisors, Inc	13F	Company	0.02%	5,000	$11,000	—	31 Dec 2020	13F
GROUP ONE TRADING LLC	13F	Company	0.02%	4,500	$10,000	—	31 Dec 2020	13F
OSAIC HOLDINGS, INC.	13F	Company	0.01%	3,590	$8,000	—	31 Dec 2020	13F
Federation Des Caisses Desjardins du Quebec	13F	Individual	0.01%	3,500	$7,665	—	31 Dec 2020	13F
UBS Group AG	13F	Company	0%	626	$1,000	—	31 Dec 2020	13F
Valeo Financial Advisors, LLC	13F	Company	0%	500	$1,000	—	31 Dec 2020	13F

Institutional Holders of Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) as of Q1 2021

As of 31 Mar 2021, Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) was held by 39 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,972,408 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, SABBY MANAGEMENT, LLC, Virtu Financial LLC, GSA CAPITAL PARTNERS LLP, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, and BANK OF AMERICA CORP /DE/. This page lists 39 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

Q1 2021 holders

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.